Relevance of randomised controlled trials in oncology
Author:
Publisher
Elsevier BV
Subject
Oncology
Reference75 articles.
1. Evolution of the randomized controlled trial in oncology over three decades;Booth;J Clin Oncol,2008
2. Role of cooperative groups and funding source in clinical studies that support approved therapy for breast cancer;Anguera;Eur J Cancer,2015
3. Absolute benefits of medical therapies in phase III clinical trials for breast and colorectal cancer;Seruga;Ann Oncol,2010
4. Evolution in the eligibility criteria of randomized controlled trials for systemic cancer therapies;Srikanthan;Cancer Treat Rev,2016
5. High-dose methotrexate in the treatment of malignant mesothelioma of the pleura. A phase II study;Solheim;Br J Cancer,1992
Cited by 78 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Using non-randomized trials to assess the clinical benefit of systemic anti-cancer treatments: Viable or not?;European Journal of Cancer;2024-09
2. Health-related quality of life outcomes reporting associated with FDA approvals in haematology and oncology;BMJ Oncology;2024-07
3. [Translated article] Characteristics, clinical benefit, and reimbursement of new authorisations for oncohaematology drugs in Spain between 2017 and 2020;Farmacia Hospitalaria;2024-07
4. Composite event-free-survival as an endpoint in oncology drug evaluation: Review and guidance perspectives from the Haute Autorité de Santé (HAS);European Journal of Cancer;2024-06
5. Global cooperation and early access—clinical outcomes matter;The Lancet Oncology;2024-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3